PDGFRB and rhabdomyosarcoma: Nevertheless, the three responses in patients with rhabdomyosarcoma merit further comment, particularly in light of initial data showing activity of olaratumab in combination with doxorubicin in adults with STS and the known role of the PDGFR pathway in rhabdomyosarcoma.